OTC - ACTIVE INGREDIENT SECTION
Active ingredient Purpose
Hydroquinone 2% Skin Lightener
Active ingredient Purpose
Hydroquinone 2% Skin Lightener
Uses: For the gradual fading of drark (brownish) areas in the skin such as freckles, age and liver spots.
Keep out of reach of children. If product is swallowed, get medical help or call the Poison Control Center right away.
When using this product avoid contat with eyes
Warnings:
Directions
Inactive ingredients:
Water, Propylene Glycol, Caprylic/Capric Triglyceride, Glyceryl Stearate, Isopropyl Palmitate, Butylene Glycol, Glycerin, PEG-100 Stearate, Cetearyl Alcohol, Azelaic Acid, Cetyl Phosphate, Triethanolamine, Arbutin, Frangrance, Kojic Acid, Phenylehtyl Resorcinol, Rumex Occidentalis Extract, Lactic Acid, Sodium Ascorbyl Phosphate, Dimethicone, Aloe Barbadensis Leaf Extract, Arctostaphylos Uva-Ursi Leaf Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Morus Alba Fruit Extract, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Zea Mays (Corn) Oil, Ceteth-10 Phosphate, Dicetyl Phosphate, Bisabolol, Ascorbic Acid, Pentylene Glycol, Sebacic Acid, Suberic Acid, Xanthan Gum, Tetrasodium EDTA, BHT, Undecanedioc Acid, Sodium Metabisulfate, Dehydroacetic Acid, Benzyl Alcohol.
Lightening Cream + HQ Spot Treatment
1.7Fl Oz/ 50mL
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 72274-001 | 72274-001-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d076ce11-3d82-5c35-e053-2a95a90ac887 | 29bcbd35-2459-411c-b0bf-d6d88594f62f | 2021-11-10 | Warnings | 29bcbd35-2459-411c-b0bf-d6d88594f62f |
Adverse event summaries are temporarily unavailable. Other product information remains available.